KRT72 might serves as a prognostic biomarker for patients with prostate cancer

Asian J Surg. 2023 Nov;46(11):5382-5384. doi: 10.1016/j.asjsur.2023.07.097. Epub 2023 Sep 4.

Authors

Jie Wang¹, Yuhan Xiao¹, Qingxin Yu², Chi Zhang³

Affiliations

¹ Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; West China School of medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
² Ningbo Diagnostic Pathology Center, Ningbo City, Zhejiang Province, China.
³ Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, PR China. Electronic address: chizhang_swmu@126.com.

PMID: 37673738
DOI: 10.1016/j.asjsur.2023.07.097

No abstract available

Keywords: Cancer biomarker; KRT72; Prostate cancer; Tumor immune microenvironment.

Publication types

Letter

MeSH terms

Biomarkers, Tumor
Humans
Male
Prognosis
Prostatic Neoplasms*

Substances

Biomarkers, Tumor